Kazia Therapeutics (KZIA) Income from Continuing Operations (2009 - 2024)
Kazia Therapeutics' (KZIA) quarterly Income from Continuing Operations came in at 3186367.55 in Q4 2016, up 72.0% on a QoQ basis from 11379539.93 in Q4 2012.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Income from Continuing Operations (2009 - 2024) Analysis & Trends
Kazia Therapeutics (KZIA) has 5 years of Income from Continuing Operations data on file, last reported at 3186367.55 in Q4 2016.
- Quarterly Income from Continuing Operations changed N/A year-over-year to 3186367.55 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 20650444.29 (changed N/A YoY) and the FY2025 annual result came in at 13258248.17, up 24.87% from the prior year.
- Income from Continuing Operations rose to 3186367.55 in Q4 2016, from 11379539.93 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3186367.55 in Q4 2016 to a low of 11379539.93 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 601.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Kazia Therapeutics | 91.11 Mn | 91.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -7.01 Mn |
| Jun 30, 2024 | -178,595.64 |
| Dec 31, 2023 | -176,418.42 |
| Dec 31, 2022 | -9.10 Mn |
| Dec 31, 2021 | -9.62 Mn |
| Aug 30, 2013 | -5.22 Mn |
| Dec 31, 2012 | -8.16 Mn |
| Dec 31, 2011 | 14.95 Mn |
| Dec 31, 2010 | 16.91 Mn |
| Jun 30, 2010 | 35.77 Mn |
| Dec 31, 2009 | 16.99 Mn |